ArticleProceedings. IEEE International Conference on Bioinformatics and Biomedicine2025
A Knowledge-Guided Large Language Model Framework for Microbiome-Based Disease Diagnosis.
Article in Proceedings. IEEE International Conference on Bioinformatics and Biomedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Gut microbiome-based disease diagnosis holds significant promise but remains challenging due to the high data dimensionality, typically small sample sizes, and the necessity of incorporating biological knowledge. Due to these challenges, traditional machine learning approaches often tend to overfit the data and fail to capture true biological relationships, resulting in inaccurate diagnoses. To fill in the gap, we propose a two-phase, knowledge-guided large language model (LLM) framework for disease diagnosis that integrates biomedical expertise with in-context learning. In Phase 1, an LLM is employed to identify disease-associated taxa from hundreds of microbial families and to infer their biological relationships with the disease outcome. This process reduces the feature space dimensionality through biologically-informed feature selection and acquires essential domain knowledge. In Phase 2, we employ few-shot prompting to guide the LLM in disease outcome classification based on the domain knowledge acquired in Phase 1. Thanks to the universal applicability of LLM and our two-phase approach, this is a generic framework that can be applied to a wide range of microbiome-based disease diagnostic tasks. We demonstrate the superiority of our framework using inflammatory bowel disease (IBD) as a representative case study, where our approach achieves an accuracy of 73.91%, significantly outperforming an optimized XGBoost classifier. Overall, our knowledge-guided framework provides a powerful and generalizable strategy for leveraging LLMs in microbiome-based disease diagnosis, and opens a new avenue for disease diagnosis in the era of LLM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.